Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal Antibody
Crossref DOI link: https://doi.org/10.1208/s12248-019-0320-3
Published Online: 2019-03-29
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xiang, Yuhong
Parng, Chuenlei
Olson, Katrina
Seletskaia, Elena
Gorovits, Boris
Jani, Darshana
Caiazzo, Teresa
Joyce, Alison
Donley, Jean
Text and Data Mining valid from 2019-03-29
Article History
Received: 27 November 2018
Accepted: 12 March 2019
First Online: 29 March 2019